ReP USP - Resultado da busca

Artigo de periodico
Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines (2018)
Baroni, Mirella; Marie, Suely Kazue Nagahashi; Fedatto, Paola Fernanda; Andrade, Augusto Faria; Sant'Ana, Veridiana Kill Suazo de; Cruzeiro, Gustavo Alencastro Veiga; Queiroz, Rosane de Paula; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Journal of neuro-oncology. Unidades: FM, FMRP
Subjects: DIFERENCIAÇÃO CELULAR, INSUFICIÊNCIA RESPIRATÓRIA, BIÓPSIA, MÚSCULOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARONI, Mirella et al. Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines. Journal of neuro-oncology, v. 139, n. 1, p. 51-60, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-2853-1. Acesso em: 19 jun. 2024.
APA
Baroni, M., Marie, S. K. N., Fedatto, P. F., Andrade, A. F., Sant'Ana, V. K. S. de, Cruzeiro, G. A. V., et al. (2018). Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines. Journal of neuro-oncology, 139( 1), 51-60. doi:10.1007/s11060-018-2853-1
NLM
Baroni M, Marie SKN, Fedatto PF, Andrade AF, Sant'Ana VKS de, Cruzeiro GAV, Queiroz R de P, Tone LG, Scrideli CA. Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines [Internet]. Journal of neuro-oncology. 2018 ; 139( 1): 51-60.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s11060-018-2853-1
Vancouver
Baroni M, Marie SKN, Fedatto PF, Andrade AF, Sant'Ana VKS de, Cruzeiro GAV, Queiroz R de P, Tone LG, Scrideli CA. Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines [Internet]. Journal of neuro-oncology. 2018 ; 139( 1): 51-60.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s11060-018-2853-1
Artigo de periodico
TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia (2018)
Brassesco, Maria Sol; Pezuk, Julia Alejandra; Cortez, Maria Angélica; Salomão, Karina Bezerra; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Leukemia Research. Unidades: FFCLRP, FMRP
Subjects: LEUCEMIA, CRIANÇAS, PROGNÓSTICO, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, Maria Sol et al. TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia. Leukemia Research, v. 74, p. 42-46, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2018.09.010. Acesso em: 19 jun. 2024.
APA
Brassesco, M. S., Pezuk, J. A., Cortez, M. A., Salomão, K. B., Scrideli, C. A., & Tone, L. G. (2018). TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia. Leukemia Research, 74, 42-46. doi:10.1016/j.leukres.2018.09.010
NLM
Brassesco MS, Pezuk JA, Cortez MA, Salomão KB, Scrideli CA, Tone LG. TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia [Internet]. Leukemia Research. 2018 ; 74 42-46.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.leukres.2018.09.010
Vancouver
Brassesco MS, Pezuk JA, Cortez MA, Salomão KB, Scrideli CA, Tone LG. TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia [Internet]. Leukemia Research. 2018 ; 74 42-46.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.leukres.2018.09.010
Artigo de periodico
Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups (2018)
Salomão, Karina Bezerra; Cruzeiro, Gustavo Alencastro Veiga; Silva, Ricardo Bonfim; Geron, Lenisa; Ramalho, Fernando Silva; Saggioro, Fabiano Pinto; Neder, Luciano; Moreno, Daniel Antunes; Queiroz, Rosane Gomes de Paula; Aguiar, Simone dos Santos; Cardinalli, Izilda; Yunes, José Andres; Brandalise, Silvia Regina; Brassesco, Maria Sol; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Journal of Neuro-Oncology. Unidades: FMRP, SVOI, FFCLRP
Subjects: MEDULOBLASTOMA, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALOMÃO, Karina Bezerra et al. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, v. 139, n. 1, p. 33-42, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-2845-1. Acesso em: 19 jun. 2024.
APA
Salomão, K. B., Cruzeiro, G. A. V., Silva, R. B., Geron, L., Ramalho, F. S., Saggioro, F. P., et al. (2018). Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, 139( 1), 33-42. doi:10.1007/s11060-018-2845-1
NLM
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Vancouver
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Dissertação (Mestrado)
Aumento da expressão das isoformas Ik6 e Ik10 do gene IKZF1 ao diagnóstico e seu impacto no prognóstico da leucemia linfoide aguda da infância (2018)
Moreira, Larissa Bueno Polis; Scrideli, Carlos Alberto (Orientador)
Unidade: FMRP
Subjects: LEUCEMIA, SAÚDE DA CRIANÇA, INFÂNCIA, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Larissa Bueno Polis. Aumento da expressão das isoformas Ik6 e Ik10 do gene IKZF1 ao diagnóstico e seu impacto no prognóstico da leucemia linfoide aguda da infância. 2018. Dissertação (Mestrado) – Universidade de São Paulo, Ribeirão Preto, 2018. Disponível em: http://www.teses.usp.br/teses/disponiveis/17/17144/tde-08012019-163609/. Acesso em: 19 jun. 2024.
APA
Moreira, L. B. P. (2018). Aumento da expressão das isoformas Ik6 e Ik10 do gene IKZF1 ao diagnóstico e seu impacto no prognóstico da leucemia linfoide aguda da infância (Dissertação (Mestrado). Universidade de São Paulo, Ribeirão Preto. Recuperado de http://www.teses.usp.br/teses/disponiveis/17/17144/tde-08012019-163609/
NLM
Moreira LBP. Aumento da expressão das isoformas Ik6 e Ik10 do gene IKZF1 ao diagnóstico e seu impacto no prognóstico da leucemia linfoide aguda da infância [Internet]. 2018 ;[citado 2024 jun. 19 ] Available from: http://www.teses.usp.br/teses/disponiveis/17/17144/tde-08012019-163609/
Vancouver
Moreira LBP. Aumento da expressão das isoformas Ik6 e Ik10 do gene IKZF1 ao diagnóstico e seu impacto no prognóstico da leucemia linfoide aguda da infância [Internet]. 2018 ;[citado 2024 jun. 19 ] Available from: http://www.teses.usp.br/teses/disponiveis/17/17144/tde-08012019-163609/
Artigo de periodico
HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation (2018)
Cruzeiro, Gustavo Alencastro Veiga; Reis, Maristella Bergamo dos; Silveira, Vanessa da Silva; Lira, Regia Caroline Peixoto; Carlotti Júnior, Carlos Gilberto; Neder, Luciano; Oliveira, Ricardo Santos; Yunes, Jose Andres; Brandalise, Silvia Regina; Aguiar, Simone; Eterovic, Agda Karina; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto; Valera, Elvis Terci
Source: Current Cancer Drug Targets. Unidade: FMRP
Subjects: MEDULOBLASTOMA, ANÓXIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZEIRO, Gustavo Alencastro Veiga et al. HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation. Current Cancer Drug Targets, v. 18, n. 3, p. 287-294, 2018Tradução . . Disponível em: https://doi.org/10.2174/1568009617666170315162525. Acesso em: 19 jun. 2024.
APA
Cruzeiro, G. A. V., Reis, M. B. dos, Silveira, V. da S., Lira, R. C. P., Carlotti Júnior, C. G., Neder, L., et al. (2018). HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation. Current Cancer Drug Targets, 18( 3), 287-294. doi:10.2174/1568009617666170315162525
NLM
Cruzeiro GAV, Reis MB dos, Silveira V da S, Lira RCP, Carlotti Júnior CG, Neder L, Oliveira RS, Yunes JA, Brandalise SR, Aguiar S, Eterovic AK, Tone LG, Scrideli CA, Valera ET. HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation [Internet]. Current Cancer Drug Targets. 2018 ; 18( 3): 287-294.[citado 2024 jun. 19 ] Available from: https://doi.org/10.2174/1568009617666170315162525
Vancouver
Cruzeiro GAV, Reis MB dos, Silveira V da S, Lira RCP, Carlotti Júnior CG, Neder L, Oliveira RS, Yunes JA, Brandalise SR, Aguiar S, Eterovic AK, Tone LG, Scrideli CA, Valera ET. HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation [Internet]. Current Cancer Drug Targets. 2018 ; 18( 3): 287-294.[citado 2024 jun. 19 ] Available from: https://doi.org/10.2174/1568009617666170315162525
Artigo de periodico
Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines (2018)
Geron, Lenisa; Salomão, Karina Bezerra; Borges, Kleiton Silva; Andrade, Augusto Faria; Corrêa, Carolina Alves Pereira; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Cytotechnology. Unidade: FMRP
Assunto: MEDULOBLASTOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GERON, Lenisa et al. Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines. Cytotechnology, v. 70, n. 6, p. 1713-1722, 2018Tradução . . Disponível em: https://doi.org/10.1007/s10616-018-0260-2. Acesso em: 19 jun. 2024.
APA
Geron, L., Salomão, K. B., Borges, K. S., Andrade, A. F., Corrêa, C. A. P., Scrideli, C. A., & Tone, L. G. (2018). Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines. Cytotechnology, 70( 6), 1713-1722. doi:10.1007/s10616-018-0260-2
NLM
Geron L, Salomão KB, Borges KS, Andrade AF, Corrêa CAP, Scrideli CA, Tone LG. Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines [Internet]. Cytotechnology. 2018 ; 70( 6): 1713-1722.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s10616-018-0260-2
Vancouver
Geron L, Salomão KB, Borges KS, Andrade AF, Corrêa CAP, Scrideli CA, Tone LG. Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines [Internet]. Cytotechnology. 2018 ; 70( 6): 1713-1722.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s10616-018-0260-2
Curadoria
Congresso brasileiro de oncologia pediátrica, 16 (2018)
Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Lima, Regina Aparecida Garcia de
Unidades: FMRP, EERP
Subjects: ONCOLOGIA, PEDIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCRIDELI, Carlos Alberto e TONE, Luiz Gonzaga e LIMA, Regina Aparecida Garcia de. Congresso brasileiro de oncologia pediátrica, 16. . Foz de Iguaçu: SOBOPE. . Acesso em: 19 jun. 2024. , 2018
APA
Scrideli, C. A., Tone, L. G., & Lima, R. A. G. de. (2018). Congresso brasileiro de oncologia pediátrica, 16. Foz de Iguaçu: SOBOPE.
NLM
Scrideli CA, Tone LG, Lima RAG de. Congresso brasileiro de oncologia pediátrica, 16. 2018 ;[citado 2024 jun. 19 ]
Vancouver
Scrideli CA, Tone LG, Lima RAG de. Congresso brasileiro de oncologia pediátrica, 16. 2018 ;[citado 2024 jun. 19 ]
Artigo de periodico
Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma (2018)
Roberto, Gabriela Molinari; Engel, Edgard Eduard; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Brassesco, Maria Sol
Source: Pathology - Research and Practice. Unidades: FMRP, FFCLRP
Assunto: OSTEOSSARCOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROBERTO, Gabriela Molinari et al. Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma. Pathology - Research and Practice, v. 214, n. 2, p. 213-216, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.prp.2017.11.020. Acesso em: 19 jun. 2024.
APA
Roberto, G. M., Engel, E. E., Scrideli, C. A., Tone, L. G., & Brassesco, M. S. (2018). Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma. Pathology - Research and Practice, 214( 2), 213-216. doi:10.1016/j.prp.2017.11.020
NLM
Roberto GM, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma [Internet]. Pathology - Research and Practice. 2018 ; 214( 2): 213-216.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.prp.2017.11.020
Vancouver
Roberto GM, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma [Internet]. Pathology - Research and Practice. 2018 ; 214( 2): 213-216.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.prp.2017.11.020
Artigo de periodico
Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma (2018)
Delsin, L. E. A.; Roberto, G. M.; Fedatto, Paola Fernanda; Engel, Edgard Eduard; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Brassesco, Maria Sol
Source: Pathology & Oncology Research. Unidades: FMRP, FFCLRP
Subjects: MICRORNAS, OSTEOSSARCOMA, METÁSTASE NEOPLÁSICA, ADERÊNCIA CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DELSIN, L. E. A. et al. Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma. Pathology & Oncology Research, 2018Tradução . . Disponível em: https://doi.org/10.1007/s12253-017-0316-1. Acesso em: 19 jun. 2024.
APA
Delsin, L. E. A., Roberto, G. M., Fedatto, P. F., Engel, E. E., Scrideli, C. A., Tone, L. G., & Brassesco, M. S. (2018). Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma. Pathology & Oncology Research. doi:10.1007/s12253-017-0316-1
NLM
Delsin LEA, Roberto GM, Fedatto PF, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma [Internet]. Pathology & Oncology Research. 2018 ;[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s12253-017-0316-1
Vancouver
Delsin LEA, Roberto GM, Fedatto PF, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulated adhesion-associated microRNAs as prognostic predictors in childhood osteosarcoma [Internet]. Pathology & Oncology Research. 2018 ;[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s12253-017-0316-1
Artigo de periodico
A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12) (2018)
Brassesco, Maria Sol; Valera, Elvis Terci; Meyer, Claus; Marschalek, Rolf; Lopes, Bruno Almeida; Queiroz, Rosane Gomes de Paula; Calado, Rodrigo Tocantins; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Cancer Genetics. Unidades: FMRP, FFCLRP
Subjects: LEUCEMIA, PEDIATRIA, CITOGENÉTICA, CROMOSSOMO X
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, Maria Sol et al. A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12). Cancer Genetics, v. 228-229, p. 110-114, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cancergen.2018.10.006. Acesso em: 19 jun. 2024.
APA
Brassesco, M. S., Valera, E. T., Meyer, C., Marschalek, R., Lopes, B. A., Queiroz, R. G. de P., et al. (2018). A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12). Cancer Genetics, 228-229, 110-114. doi:10.1016/j.cancergen.2018.10.006
NLM
Brassesco MS, Valera ET, Meyer C, Marschalek R, Lopes BA, Queiroz RG de P, Calado RT, Scrideli CA, Tone LG. A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12) [Internet]. Cancer Genetics. 2018 ; 228-229 110-114.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.cancergen.2018.10.006
Vancouver
Brassesco MS, Valera ET, Meyer C, Marschalek R, Lopes BA, Queiroz RG de P, Calado RT, Scrideli CA, Tone LG. A new complex rearrangement in infant ALL: t(X;11;17)(p11.2;q23;q12) [Internet]. Cancer Genetics. 2018 ; 228-229 110-114.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1016/j.cancergen.2018.10.006
Trabalho de evento-resumo periodico
Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis (2017)
Moreira, L. B. P.; Queiróz, R. D. P.; Perna, E.; Suazo, V. K.; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Pediatric Blood and Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: LEUCEMIA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, L. B. P. et al. Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 19 jun. 2024. , 2017
APA
Moreira, L. B. P., Queiróz, R. D. P., Perna, E., Suazo, V. K., Tone, L. G., & Scrideli, C. A. (2017). Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Moreira LBP, Queiróz RDP, Perna E, Suazo VK, Tone LG, Scrideli CA. Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S188.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Moreira LBP, Queiróz RDP, Perna E, Suazo VK, Tone LG, Scrideli CA. Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S188.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1002/pbc.26772
Artigo de periodico
The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line (2017)
Borges, Kleiton S.; Andrade, Augusto F.; Silveira, Vanessa da Silva; Marco Antonio, David S.; Vasconcelos, Elton J.R.; Antonini, Sonir Roberto Rauber; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Anti-Cancer Drugs. Unidade: FMRP
Subjects: APOPTOSE, FÁRMACOS, ANTINEOPLÁSICOS, CARCINOMA, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Kleiton S. et al. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, v. 28, n. 6, p. 634-644, 2017Tradução . . Disponível em: https://doi.org/10.1097/cad.0000000000000504. Acesso em: 19 jun. 2024.
APA
Borges, K. S., Andrade, A. F., Silveira, V. da S., Marco Antonio, D. S., Vasconcelos, E. J. R., Antonini, S. R. R., et al. (2017). The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, 28( 6), 634-644. doi:10.1097/cad.0000000000000504
NLM
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1097/cad.0000000000000504
Vancouver
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1097/cad.0000000000000504
Artigo de periodico
The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma (2017)
Andrade, Augusto Faria; Borges, Kleiton Silva; Suazo, Veridiana Kill; Geron, Lenisa; Corrêa, Carolina Alves Pereira; Castro-Gamero, Angel Mauricio; Vasconcelos, Elton José Rosas de; Oliveira, Ricardo Santos de; Neder, Luciano; Yunes, José Andres; Aguiar, Simone dos Santos; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Investigational New Drugs. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, MEDULOBLASTOMA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Augusto Faria et al. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma. Investigational New Drugs, v. 35, n. 1, p. 26-36, 2017Tradução . . Disponível em: https://doi.org/10.1007/s10637-016-0401-4. Acesso em: 19 jun. 2024.
APA
Andrade, A. F., Borges, K. S., Suazo, V. K., Geron, L., Corrêa, C. A. P., Castro-Gamero, A. M., et al. (2017). The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma. Investigational New Drugs, 35( 1), 26-36. doi:10.1007/s10637-016-0401-4
NLM
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CAP, Castro-Gamero AM, Vasconcelos EJR de, Oliveira RS de, Neder L, Yunes JA, Aguiar S dos S, Scrideli CA, Tone LG. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma [Internet]. Investigational New Drugs. 2017 ; 35( 1): 26-36.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s10637-016-0401-4
Vancouver
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CAP, Castro-Gamero AM, Vasconcelos EJR de, Oliveira RS de, Neder L, Yunes JA, Aguiar S dos S, Scrideli CA, Tone LG. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma [Internet]. Investigational New Drugs. 2017 ; 35( 1): 26-36.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s10637-016-0401-4
Trabalho de evento-resumo periodico
Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors (2017)
Corrêa, C. A. P; Lira, R. C. P; Andrade, A. F; Yunes, J. A.; Brandalise, S. R.; Mastelllaro, M. J.; Leal, L. F.; Antonini, Sonir Roberto Rauber; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Pediatric Blood and Cancer. Conference titles: Annual Congresso of The International Society Of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: ADRENORECEPTORES, TUMOR CARCINOIDE, NEOPLASIAS, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORRÊA, C. A. P et al. Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 19 jun. 2024. , 2017
APA
Corrêa, C. A. P., Lira, R. C. P., Andrade, A. F., Yunes, J. A., Brandalise, S. R., Mastelllaro, M. J., et al. (2017). Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Corrêa CAP, Lira RCP, Andrade AF, Yunes JA, Brandalise SR, Mastelllaro MJ, Leal LF, Antonini SRR, Tone LG, Scrideli CA. Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors [Internet]. Pediatric Blood and Cancer. 2017 ; no S295-S296.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Corrêa CAP, Lira RCP, Andrade AF, Yunes JA, Brandalise SR, Mastelllaro MJ, Leal LF, Antonini SRR, Tone LG, Scrideli CA. Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors [Internet]. Pediatric Blood and Cancer. 2017 ; no S295-S296.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1002/pbc.26772
Trabalho de evento-resumo periodico
Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma (2017)
Cruzeiro, G. Alencastro Veiga; Baroni, M.; Salomão, K. Bezerra; Lira, R. C. Peixoto; Geron, L.; Andrade, A. F.; Corrêa, C. Alves; Moreno, D. Antunes; Silveira, Vanessa da Silva; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood and Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: MEDULOBLASTOMA, APOPTOSE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZEIRO, G. Alencastro Veiga et al. Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 19 jun. 2024. , 2017
APA
Cruzeiro, G. A. V., Baroni, M., Salomão, K. B., Lira, R. C. P., Geron, L., Andrade, A. F., et al. (2017). Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Cruzeiro GAV, Baroni M, Salomão KB, Lira RCP, Geron L, Andrade AF, Corrêa CA, Moreno DA, Silveira V da S, Scrideli CA, Tone LG. Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S315.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Cruzeiro GAV, Baroni M, Salomão KB, Lira RCP, Geron L, Andrade AF, Corrêa CA, Moreno DA, Silveira V da S, Scrideli CA, Tone LG. Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S315.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1002/pbc.26772
Trabalho de evento-resumo periodico
Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma (2017)
Baroni, M.; Andrade, A. F.; Cruzeiro, G. A. V.; Correa, C. A. P.; Carlotti Júnior, Carlos Gilberto; Aguiar, S; Nunes, J. A.; Brandalise, S. R.; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood and Cancer. Conference titles: Annual Congresso of The International Society Of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: MEDULOBLASTOMA, EXPRESSÃO GÊNICA, SISTEMA NERVOSO CENTRAL, TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARONI, M. et al. Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 19 jun. 2024. , 2017
APA
Baroni, M., Andrade, A. F., Cruzeiro, G. A. V., Correa, C. A. P., Carlotti Júnior, C. G., Aguiar, S., et al. (2017). Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Baroni M, Andrade AF, Cruzeiro GAV, Correa CAP, Carlotti Júnior CG, Aguiar S, Nunes JA, Brandalise SR, Scrideli CA, Tone LG. Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma [Internet]. Pediatric Blood and Cancer. 2017 ; no S315-S316.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Baroni M, Andrade AF, Cruzeiro GAV, Correa CAP, Carlotti Júnior CG, Aguiar S, Nunes JA, Brandalise SR, Scrideli CA, Tone LG. Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma [Internet]. Pediatric Blood and Cancer. 2017 ; no S315-S316.[citado 2024 jun. 19 ] Available from: https://doi.org/10.1002/pbc.26772
Artigo de periodico
Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma (2017)
Andrade, Augusto Faria; Borges, Kleiton Silva; Suazo, Veridiana Kiill; Geron, Lenisa; Corrêa, Carolina Alves Pereira; Castro-Gamero, Angel Mauricio; de Vasconcelos, Elton José Rosas; Oliveira, Ricardo Santos de; Neder, Luciano; Yunes, José Andres; Aguiar, Simone dos Santos; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Investigational New Drugs. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, MEDULOBLASTOMA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Augusto Faria et al. Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma. Investigational New Drugs, v. 35, n. 1, 2017Tradução . . Disponível em: https://doi.org/10.1007/s10637-016-0412-1. Acesso em: 19 jun. 2024.
APA
Andrade, A. F., Borges, K. S., Suazo, V. K., Geron, L., Corrêa, C. A. P., Castro-Gamero, A. M., et al. (2017). Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma. Investigational New Drugs, 35( 1). doi:10.1007/s10637-016-0412-1
NLM
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CAP, Castro-Gamero AM, de Vasconcelos EJR, Oliveira RS de, Neder L, Yunes JA, Aguiar S dos S, Scrideli CA, Tone LG. Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma [Internet]. Investigational New Drugs. 2017 ; 35( 1):[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s10637-016-0412-1
Vancouver
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CAP, Castro-Gamero AM, de Vasconcelos EJR, Oliveira RS de, Neder L, Yunes JA, Aguiar S dos S, Scrideli CA, Tone LG. Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma [Internet]. Investigational New Drugs. 2017 ; 35( 1):[citado 2024 jun. 19 ] Available from: https://doi.org/10.1007/s10637-016-0412-1
Artigo de periodico
The antiproliferative and pro-apoptotic effects of methoxyamine on pediatric medulloblastoma cell lines exposed to ionizing radiation and chemotherapy (2016)
Pezuk, Julia A.; Valera, Elvis Terci; Delsin, Lara Elis Alberici; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Brassesco, Maria Sol
Source: Central Nervous System Agents in Medicinal Chemistry. Unidades: FFCLRP, FMRP
Subjects: MEDULOBLASTOMA, QUIMIOTERAPIA, RADIAÇÃO IONIZANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEZUK, Julia A. et al. The antiproliferative and pro-apoptotic effects of methoxyamine on pediatric medulloblastoma cell lines exposed to ionizing radiation and chemotherapy. Central Nervous System Agents in Medicinal Chemistry, v. 16, n. 1, p. 67-72, 2016Tradução . . Acesso em: 19 jun. 2024.
APA
Pezuk, J. A., Valera, E. T., Delsin, L. E. A., Scrideli, C. A., Tone, L. G., & Brassesco, M. S. (2016). The antiproliferative and pro-apoptotic effects of methoxyamine on pediatric medulloblastoma cell lines exposed to ionizing radiation and chemotherapy. Central Nervous System Agents in Medicinal Chemistry, 16( 1), 67-72.
NLM
Pezuk JA, Valera ET, Delsin LEA, Scrideli CA, Tone LG, Brassesco MS. The antiproliferative and pro-apoptotic effects of methoxyamine on pediatric medulloblastoma cell lines exposed to ionizing radiation and chemotherapy. Central Nervous System Agents in Medicinal Chemistry. 2016 ; 16( 1): 67-72.[citado 2024 jun. 19 ]
Vancouver
Pezuk JA, Valera ET, Delsin LEA, Scrideli CA, Tone LG, Brassesco MS. The antiproliferative and pro-apoptotic effects of methoxyamine on pediatric medulloblastoma cell lines exposed to ionizing radiation and chemotherapy. Central Nervous System Agents in Medicinal Chemistry. 2016 ; 16( 1): 67-72.[citado 2024 jun. 19 ]
Artigo de periodico
The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines (2016)
Andrade, Pamela Viani de; Andrade, Augusto Faria; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Valera, Elvis Terci
Source: Cancer Cell International. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, SISTEMA NERVOSO CENTRAL, NEOPLASIAS DO SISTEMA NERVOSO, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Pamela Viani de et al. The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines. Cancer Cell International, v. 16, 2016Tradução . . Disponível em: https://doi.org/10.1186/s12935-016-0306-5. Acesso em: 19 jun. 2024.
APA
Andrade, P. V. de, Andrade, A. F., Queiroz, R. G. de P., Scrideli, C. A., Tone, L. G., & Valera, E. T. (2016). The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines. Cancer Cell International, 16. doi:10.1186/s12935-016-0306-5
NLM
Andrade PV de, Andrade AF, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines [Internet]. Cancer Cell International. 2016 ; 16[citado 2024 jun. 19 ] Available from: https://doi.org/10.1186/s12935-016-0306-5
Vancouver
Andrade PV de, Andrade AF, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines [Internet]. Cancer Cell International. 2016 ; 16[citado 2024 jun. 19 ] Available from: https://doi.org/10.1186/s12935-016-0306-5
Artigo de periodico
Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients (2016)
Abduch, Rafael H.; Bueno, Ana Carolina; Leal, Letícia F.; Cavalcanti, Marcelo M.; Gomes, Débora C.; Brandalise, Silvia R.; Masterallo, Maria J.; Yunes, José A.; Martinelli Júnior, Carlos Eduardo; Tone, Luiz Gonzaga; Tucci Júnior, Silvio; Molina, Carlos Augusto Fernandes; Ramalho, Fernando Silva; Moreira, Ayrton Custódio; Cardinalli, Izilda A.; Scrideli, Carlos Alberto; Ramalho, Leandra Naíra Zambelli; Castro, Margaret de; Antonini, Sonir Roberto Rauber
Source: Oncotarget. Unidade: FMRP
Subjects: PROTEÍNAS PROTO-ONCOGÊNICAS, EXPRESSÃO GÊNICA, NEOPLASIAS DO CÓRTEX SUPRARRENAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABDUCH, Rafael H. et al. Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients. Oncotarget, v. 7, n. 51, p. 84634-84644, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.12382. Acesso em: 19 jun. 2024.
APA
Abduch, R. H., Bueno, A. C., Leal, L. F., Cavalcanti, M. M., Gomes, D. C., Brandalise, S. R., et al. (2016). Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients. Oncotarget, 7( 51), 84634-84644. doi:10.18632/oncotarget.12382
NLM
Abduch RH, Bueno AC, Leal LF, Cavalcanti MM, Gomes DC, Brandalise SR, Masterallo MJ, Yunes JA, Martinelli Júnior CE, Tone LG, Tucci Júnior S, Molina CAF, Ramalho FS, Moreira AC, Cardinalli IA, Scrideli CA, Ramalho LNZ, Castro M de, Antonini SRR. Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients [Internet]. Oncotarget. 2016 ; 7( 51): 84634-84644.[citado 2024 jun. 19 ] Available from: https://doi.org/10.18632/oncotarget.12382
Vancouver
Abduch RH, Bueno AC, Leal LF, Cavalcanti MM, Gomes DC, Brandalise SR, Masterallo MJ, Yunes JA, Martinelli Júnior CE, Tone LG, Tucci Júnior S, Molina CAF, Ramalho FS, Moreira AC, Cardinalli IA, Scrideli CA, Ramalho LNZ, Castro M de, Antonini SRR. Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients [Internet]. Oncotarget. 2016 ; 7( 51): 84634-84644.[citado 2024 jun. 19 ] Available from: https://doi.org/10.18632/oncotarget.12382

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration

Área de concentração